Drug Markets/Bromfenac

Bromfenac

6 NDCs across 4 manufacturers|5 Generic,1 Brand

Bromfenac is used to treat eye pain, inflammation and postoperative pain, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Bromfenac is available as 6 NDCs from 4 manufacturers (5 generic, 1 brand), with NADAC prices from $15.63 to $49.55 per ML — the most expensive product costs about 3.2× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

6

5G / 1B

Manufacturers

4

competing in market

Price Spread

$15.63 – $49.55

per ML

7d Activity

3↑3↓0 flat

avg +0.3% WoW · of 6 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Drug Portfolio

6 NDCs total, 6 shown

Frequently Asked Questions

What is Bromfenac used to treat?

Bromfenac is used to treat eye pain, inflammation and postoperative pain, per the National Library of Medicine's MED-RT classification.

How many Bromfenac products are on the market?

The Bromfenac drug market contains 6 NDCs from 4 manufacturers — 5 generic and 1 brand product.

What is the price range for Bromfenac?

NADAC reference prices for Bromfenac range from $15.6341 to $49.5534 per ML — the most expensive product costs about 3.2× the cheapest.

Is generic Bromfenac cheaper than brand?

The average generic NADAC for Bromfenac is $19.1344 per ML, versus $49.5534 for brand-labeled products — brand versions average about 2.6× the generic price.

Which manufacturers make Bromfenac?

4 manufacturers list Bromfenac in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (2), Lupin Pharmaceuticals Inc. (2), Aurobindo Pharma Limited (1), Fosun Pharma USA Inc. (1).

How has the price of Bromfenac changed recently?

Over the past 7 days, 3 Bromfenac NDCs rose and 3 fell, with a market-wide average change of +0.3%.